← Back to search

ORGANOGENESIS HOLDINGS INC.

ORGO · NASDAQ

Research and Development in Biotechnology

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis's comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

ESG Scores

Overall ESG
2.1
Environmental
4.6
Social
2.5
Governance
5.7

Gender Diversity

Female Directors0.0909%
Female Executives0.06134969325153374%
CEO GenderMale